SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19. Nader D, Fletcher N, Curley GF, Kerrigan SW, et al. PLoS One 2021;16:e0253347.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nader D, Fletcher N, Curley GF, Kerrigan SW, et al. SARS-CoV-2 uses major endothelial integrin alphavbeta3 to cause vascular dysregulation in-vitro during COVID-19. PLoS One 2021;16:e0253347.
PMID: 34161337